Yield10 Bioscience, Inc. (YTEN) Reports In-Line Q1 EPS

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q1 EPS of ($0.68), in-line with the analyst estimate of ($0.68). Revenue for the quarter came in at $149 thousand versus the consensus estimate of $160 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c